Medical Device Global Market Access copertina

Medical Device Global Market Access

Medical Device Global Market Access

Di: Pure Global
Ascolta gratuitamente

A proposito di questo titolo

 Navigate every market. Accelerate every launch. Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut. Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other regimes, showing exactly how long each milestone really takes and where companies get stuck. • First-hand war stories – Hear candid interviews with regulatory veterans who have shepherded implants, software, wearables, diagnostics, and AI algorithms to market—and lived to tell the tale. • Real-time intelligence – Every episode covering the week’s new guidances, standards, and enforcement trends so you’re always ahead of the curve. • Actionable templates – From clinical evaluation checklists to technical-file skeletons, we break down the documents you’ll need and the pitfalls reviewers love to flag. • AI-powered insights – Because Pure Global mines millions of public filings, tenders, and recalls, we surface data-backed best practices you won’t hear at conferences—or from competitors. What you’ll hear • Launching SaMD under multiple risk classes in parallel • Surviving an unannounced ISO 13485 audit • Building a “reg-first” QMS that scales • Mastering Latin-American registrations without endless language cycles • Leveraging real-world evidence to shorten clinical timelines • Aligning cybersecurity, privacy, and post-market surveillance rules across regions Whether you’re plotting first entry, managing lifecycle expansions, or rescuing a delayed submission, subscribing could shave months—and millions—off your path to revenue. ⸻ Brought to you by Pure Global – the AI-native consultancy that already guides MedTech innovators through regulatory and market-access hurdles in 30 + countries. Ready for expert help on your next submission? Visit https://pureglobal.com or email info@pureglobal.com to start accelerating today.Copyright 2026 Pure Global
Episodi
  • EU MDR Clinical Evidence: Mastering CERs, PMCF, and Equivalence Arguments

    EU MDR Clinical Evidence: Mastering CERs, PMCF, and Equivalence Arguments
    Jan 30 2026
    This episode delves into the stringent clinical evidence requirements under the European Union's Medical Device Regulation (MDR 2017/745). We explore the top challenges manufacturers face, including the heightened standards for clinical evaluation plans and reports (CEPs/CERs), the complexities of justifying 'sufficient data,' the difficulties in making equivalence arguments, and the continuous nature of Post-Market Clinical Follow-up (PMCF). Key Questions - What does "sufficient clinical evidence" truly mean under the EU MDR? - Why are so many companies forced to rewrite their Clinical Evaluation Reports (CERs)? - How have the rules for claiming equivalence to another device changed? - Is Post-Market Clinical Follow-up (PMCF) optional or a continuous requirement? - How do you align your marketing claims, risk management, and PMS data? - What are the biggest clinical data hurdles for borderline and Class IIa/IIb devices? - How can you prepare your clinical evaluation for stricter Notified Body scrutiny? Pure Global streamlines global market access for MedTech and IVD companies navigating complex regulations like the EU MDR. Our experts develop robust regulatory strategies and use advanced AI to efficiently compile technical dossiers and Clinical Evaluation Reports, ensuring alignment with Notified Body expectations. We manage the entire lifecycle, from pre-submission to Post-Market Clinical Follow-up and surveillance, acting as your local representative in over 30 markets. Let us help you meet the high standards for clinical evidence and accelerate your entry into the EU and beyond. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.
    Mostra di più Mostra meno
    3 min
  • EU MDR & IVDR Certification: Navigating the Notified Body Capacity Crunch and Timeline Compression

    EU MDR & IVDR Certification: Navigating the Notified Body Capacity Crunch and Timeline Compression
    Jan 29 2026
    This episode delves into the ongoing Notified Body capacity crisis for EU MDR and IVDR certification. Despite extended transition deadlines, significant bottlenecks in audit scheduling and technical documentation review are creating a "timeline compression" risk. We explore why manufacturers must strategically prioritize their product portfolios and engage with Notified Bodies much earlier than planned to avoid jeopardizing market access as deadlines approach. - Why is Notified Body availability still a major risk despite MDR/IVDR deadline extensions? - What is "timeline compression" and how does it affect legacy devices? - How should manufacturers strategically prioritize products for EU certification? - What are the hidden delays in scheduling audits and technical file reviews? - Was the May 26, 2024 application deadline a false finish line? - Are the extended transition periods creating a false sense of security? - What steps can you take now to secure your place in the certification queue? Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies, leveraging local expertise and advanced AI to accelerate global market access. We develop efficient regulatory strategies, assist with technical dossier submissions, and act as your local representative in over 30 markets to get your products approved efficiently. Our technology-driven approach streamlines compliance and market research, helping you navigate complex environments like the EU. Whether you are a startup or a multinational, we have scalable solutions to support your expansion. Contact us at info@pureglobal.com, visit https://pureglobal.com/, or explore our FREE AI tools and database at https://pureglobal.ai.
    Mostra di più Mostra meno
    3 min
  • EU MDR & IVDR Simplification: What the 2025 Proposal Means for MedTech

    EU MDR & IVDR Simplification: What the 2025 Proposal Means for MedTech
    Jan 28 2026
    This episode unpacks the European Commission's significant proposal of December 16, 2025, aimed at the targeted simplification of the MDR and IVDR. We explore the potential impacts on documentation, digitalization through EUDAMED, and what these changes could mean for manufacturers, especially SMEs, as they navigate the complex European regulatory landscape. Key Questions: - What specific changes are included in the EU Commission's "targeted simplification" proposal? - How could the proposed MDR/IVDR updates affect documentation and compliance costs? - What role will digitalization and the mandatory use of EUDAMED play in the future? - Are Small and Medium-sized Enterprises (SMEs) specifically addressed in this proposal? - What is the legislative timeline, and when might these changes take effect? - Should manufacturers alter their current regulatory strategy based on this news? - How will the proposal impact market access and device availability in the EU? Pure Global offers end-to-end regulatory consulting solutions for MedTech and IVD companies, combining local expertise with advanced AI and data tools to streamline global market access. We develop efficient pathways for regulatory approval, using AI to compile and submit technical documents, and act as your local representative in over 30 markets. Whether you're a startup or a multinational enterprise, our technology-driven approach ensures you can navigate complex environments and bring innovations to market faster. Visit us at https://pureglobal.com/, contact info@pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.
    Mostra di più Mostra meno
    3 min
Ancora nessuna recensione